CLINICAL SUPPLY MANAGEMENT ARTICLES
The End Of Just-In-Time? Why Clinical Trial Supply Chains Are Rethinking Inventory Strategy
Clinical trials are too unpredictable for inventory strategies built on fixed assumptions. Learn why agility, visibility and smarter buffers are becoming essential to supply planning.
CLINICAL SUPPLY MANAGEMENT RESOURCES
-
Learn why the ability to get investigational products to sites, and appropriately store them, is not a given – and this oversight can have serious consequences.
-
Consider how integrated response technologies and electronic clinical outcomes assessments can improve configurability, study start-up, and flexible mid-study changes.
-
The pandemic created additional obstacles for the clinical supply chain. Ensuring continued clinical trial operation requires an optimal management solution for clinical material supply.
-
Explore modern decentralized trials that bring the supply chain into the patient experience. and including the pros and cons of direct-to-patient models.
-
Since the FDA is now encouraging creativity in trial designs, it is important for all stakeholders to adapt processes to follow the science and ultimately bring medicines to patients, faster. This white paper addresses the complexities that come with these trial designs, and how randomization and trial supply management (RTSM) solutions are critical to run flexible, robust, and quality-driven trials.
-
How to incorporate flexibility in planning to overcome potential challenges, the value of having a contingency plan, and how a risk-based approach can determine where a contingency plan is needed.
-
This white paper provides a comprehensive overview of the current supply planning landscape, identifies gaps inhibiting supply professionals from optimizing their supply chain, and delves into solutions for driving efficiencies from a people, process and technology perspective.